Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2021-12-17 00:00:00 ET · period of report 2021-12-10 · accession 0001567619-21-022297 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-17 | 2021-12-15+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | S - Sale+OE | $83.69 | -12.0K | 303.7K | -4% | -$1.00M |
| DM | 2021-12-17 | 2021-12-15+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $37.46 | +12.0K | 309.7K | +4% | +$449.5K |
| D | 2021-12-17 | 2021-12-10 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | G - Gift | $0.00 | -700 | 303.7K | -0.2% | $0 |
| DM | 2021-12-17 | 2021-12-15+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | M - OptEx | $0.00 | -12.0K | 125.0K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-16 | S | D | 6,000 | $84.68 | 303,689 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on October 13, 2021. |
| 2 | Common | Common Stock | 2021-12-16 | M | A | 6,000 | $37.46 | 309,689 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on October 13, 2021. |
| 3 | Common | Common Stock | 2021-12-15 | S | D | 6,000 | $82.71 | 303,689 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on October 13, 2021. |
| 4 | Common | Common Stock | 2021-12-15 | M | A | 6,000 | $37.46 | 309,689 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on October 13, 2021. |
| 5 | Common | Common Stock | 2021-12-10 | G | D | 700 | $0.00 | 303,689 | D | — | — | (F1) On December 10, 2021 the reporting person gifted 700 shares to an educational institution. |
| 6 | Derivative | Stock Option (Right to buy Common Stock) | 2021-12-15 | M | D | 6,000 | $0.00 | 131,000 | D | $37.46 · 2012-11-08 to 2022-05-07 | 6,000 Common Stock | (F2) Trade made pursuant to a 10b5-1 plan executed on October 13, 2021. (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |
| 7 | Derivative | Stock Option (Right to buy Common Stock) | 2021-12-16 | M | D | 6,000 | $0.00 | 125,000 | D | $37.46 · 2012-11-08 to 2022-05-07 | 6,000 Common Stock | (F2) Trade made pursuant to a 10b5-1 plan executed on October 13, 2021. (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |